Labshares Newton Launches Near Capacity and Announces Expansion Plans
Press Releases
Related or similar articles
August 19, 2019
Angel-Funded Siamab Completes $202 Million Exit with Large Commercial-Stage Biopharma
Siamab Therapeutics, Inc., a biopharmaceutical company developing novel glycan-targeted cancer therapeutics, has entered into a strategic agreement valued at up to $202 million with an undisclosed, large commercial-stage biopharmaceutical company ...
Member News
January 21, 2025
Labshares and Thermo Fisher Scientific Announce Five-Year Renewal and Expansion of Partnership
Press Releases
May 17, 2024
Streamlining Procurement: Labshares Partners with Labviva for Enhanced Access and Efficiency
In the fast-paced world of biotech innovation, easy access to crucial resources is vital for research success. That's why Labshares is excited to share news of our partnership with Labviva, a top procurement platform reshaping how scientists obtain l
Labshares News